Yin-xiao Du

Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2"

Xiaoping Chen, Yin-xiao Du, 2020, Clinical pharmacology and therapeutics.

Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

Xiaoping Chen, Yin-xiao Du, 2020, Clinical pharmacology and therapeutics.

Influence of GAS5/MicroRNA‐223‐3p/P2Y12 Axis on Clopidogrel Response in Coronary Artery Disease

He Li, Xiaolei Hu, Mupeng Li, 2021, Journal of the American Heart Association.

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients

Han Yan, Xiao-Qing Yuan, Xiaoping Chen, 2019, Journal of Translational Medicine.

Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease

Mupeng Li, Pei-Yuan Song, Q. Ma, 2020, European Journal of Clinical Pharmacology.

GAS5 promotes cytarabine induced myelosuppression via inhibition of hematopoietic stem cell differentiation.

Yin-xiao Du, Xiao-Ping Chen, Jing Yang, 2024, Toxicology and applied pharmacology.

Influence of DNMT3A R882 mutations on AML prognosis determined by the allele ratio in Chinese patients

Han Yan, Xiao-Qing Yuan, Xiaoping Chen, 2019, Journal of Translational Medicine.

Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile

Yin-xiao Du, Xiaoping Chen, Tao Wang, 2024, Journal of translational medicine.